Abstract
In the TROFI II randomized trial, it was demonstrated that stenting of culprit lesions with bioresorbable vascular scaffolds (Absorb [Abbott Vascular, Santa Clara, CA, USA]) in the setting of ST-segment elevation myocardial infarction (STEMI) resulted in a nearly complete arterial healing and low
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
